The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up
Open accessAbstract
C3 Glomerulonephritis (C3GN) is a recently described disorder that typically results from abnormalities in the alternative pathway of complement. Here, we describe the clinical features, kidney biopsy findings, alternative pathway abnormalities, glomerular proteomic profile, and follow-up in 12 cases of C3GN. This disorder equally affected all ages, both genders, and typically presented with hematuria and proteinuria. In both the short and long term, renal function remained stable in the majority of patients with native kidney disease. In two patients, C3GN recurred within one year of transplantation and resulted in a decline in allograft function. Kidney biopsy mainly showed a membranoproliferative pattern; although both mesangial proliferative and diffuse endocapillary proliferative glomerulonephritis were noted. Alternative pathway abnormalities were heterogeneous; both acquired and genetic. The most common acquired abnormality was the presence of C3 nephritic factors, while the most common genetic finding was the presence of H402 and V62 alleles of Factor H. In addition to these risk factors, other abnormalities included Factor H auto-antibodies and mutations in CFH, CFI and CFHR genes. Laser dissection and mass spectrometry of glomeruli from patients with C3GN showed accumulation of alternative pathway and terminal complement complex proteins. Thus, C3GN results from diverse abnormalities of the alternative complement pathway leading to subsequent glomerular injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Statistical Model for Identifying Proteins by Tandem Mass Spectrometry
Nesvizhskii, A. I., Keller, A., Kolker, E., & Aebersold, R. (2003) · Analytical Chemistry · doi:10.1021/ac0341261 · Cited by 4,809
Hageman, G. S., Anderson, D. H., Johnson, L. V., Hancox, L. S., Taiber, A. J., Hardisty, L. I., Hageman, J. L., Stockman, H. A., Borchardt, J. D., Gehrs, K. M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501536102 · Cited by 1,961
Self-citationVrana, J. A., Gamez, J. D., Madden, B. J., Theis, J. D., Bergen, H. R., & Dogan, A. (2009) · Blood · doi:10.1182/blood-2009-07-230722 · Cited by 904
Self-citationComplement factor H binds malondialdehyde epitopes and protects from oxidative stress
Weismann, D., Hartvigsen, K., Lauer, N., Bennett, K. L., Scholl, H. P. N., Issa, P. C., Cano, M., Brandstätter, H., Tsimikas, S., Skerka, C., et al. (2011) · Nature · doi:10.1038/nature10449 · Cited by 533 · cited 1×
“These polymorphisms lead to increased baseline AP activity even in normal controls, and studies comparing the H402 and Y402 variants of Factor H have shown that the former is associated with poorer AP control secondary to decreased binding to both endothelial cells and lipid peroxidation products like malondialdehyde,…”
ResultC3 glomerulopathy: a new classification
Fakhouri, F., Frémeaux-Bacchi, V., Noël, L.-H., Cook, H. T., & Pickering, M. C. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.85 · Cited by 363
Gale, D. P., de Jorge, E. G., Cook, H. T., Martinez-Barricarte, R., Hadjisavvas, A., McLean, A. G., Pusey, C. D., Pierides, A., Kyriacou, K., Athanasiou, Y., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60670-8 · Cited by 327
Servais, A., Frémeaux-Bacchi, V., Lequintrec, M., Salomon, R., Blouin, J., Knebelmann, B., Grünfeld, J.-P., Lesavre, P., Noël, L.-H., & Fakhouri, F. (2007) · Journal of Medical Genetics · doi:10.1136/jmg.2006.045328 · Cited by 291
New Approaches to the Treatment of Dense Deposit Disease
Smith, R. J. H., Alexander, J., Barlow, P. N., Botto, M., Cassavant, T. L., Cook, H. T., de Córdoba, S. R., Hageman, G. S., Jokiranta, T. S., Kimberling, W. J., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007030356 · Cited by 263
Self-citationHeurich, M., Martínez-Barricarte, R., Francis, N. J., Roberts, D. L., Rodríguez de Córdoba, S., Morgan, B. P., & Harris, C. L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019338108 · Cited by 231
Abrera-Abeleda, M. A., Nishimura, C., Smith, J. L. H., Sethi, S., McRae, J. L., Murphy, B. F., Silvestri, G., Skerka, C., Józsi, M., Zipfel, P. F., et al. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2005.038315 · Cited by 216
Self-citationSethi, S., & Fervenza, F. C. (2011) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2011.06.005 · Cited by 213
Self-citationSethi, S., Gamez, J. D., Vrana, J. A., Theis, J. D., Robert Bergen, H., Zipfel, P. F., Dogan, A., & Smith, R. J. H. (2009) · Kidney International · doi:10.1038/ki.2008.657 · Cited by 200
Self-citationDefective complement control of factor H (Y402H) and FHL-1 in age-related macular degeneration
Skerka, C., Lauer, N., Weinberger, A. A. W. A., Keilhauer, C. N., Sühnel, J., Smith, R., Schlötzer–Schrehardt, U., Fritsche, L., Heinen, S., & Hartmann, A. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.02.012 · Cited by 197 · cited 1×
“These polymorphisms lead to increased baseline AP activity even in normal controls, and studies comparing the H402 and Y402 variants of Factor H have shown that the former is associated with poorer AP control secondary to decreased binding to both endothelial cells and lipid peroxidation products like malondialdehyde,…”
ResultSelf-citationCauses of Alternative Pathway Dysregulation in Dense Deposit Disease
Zhang, Y., Meyer, N. C., Wang, K., Nishimura, C., Frees, K., Jones, M., Katz, L. M., Sethi, S., & Smith, R. J. H. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07900811 · Cited by 188
Self-citationProliferative Glomerulonephritis Secondary to Dysfunction of the Alternative Pathway of Complement
Sethi, S. M., Fervenza, F. C., Zhang, Y., Nasr, S. H., Leung, N., Vrana, J. A., Cramer, C. H., Nester, C., & Smith, R. J. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07110810 · Cited by 146
Self-citationRecurrent membranoproliferative glomerulonephritis after kidney transplantation
Lorenz, E. C., Sethi, S. M., Leung, N., Dispenzieri, A. A., Fervenza, F. C., & Cosio, F. G. (2010) · Kidney International · doi:10.1038/ki.2010.1 · Cited by 144
Self-citationDense Deposit Disease Associated With Monoclonal Gammopathy of Undetermined Significance
Sethi, S. M., Sukov, W. R., Zhang, Y., Fervenza, F. C., Lager, D. J., Miller, D. V., Cornell, L. D., Krishnan, S. G. S., & Smith, R. J. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.06.021 · Cited by 121
Self-citationAllelic Variants of Complement Genes Associated with Dense Deposit Disease
Abrera-Abeleda, M. A., Nishimura, C. J., Frees, K. L., Jones, M. P., Maga, T., Katz, L. M., Zhang, Y., & Smith, R. J. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010080795 · Cited by 96
Self-citationClinical features and outcomes of 98 children and adults with dense deposit disease
Lu, D.-F., Moon, M., Lanning, L. D., McCarthy, A. M., & Smith, R. J. (2011) · Pediatric Nephrology · doi:10.1007/s00467-011-2059-7 · Cited by 91
Self-citationC3 deposition glomerulopathy due to a functional Factor H defect
Habbig, S., Mihatsch, M. J., Heinen, S., Beck, B. B., Emmel, M., Skerka, C., Kirschfink, M., Höppe, B., Zipfel, P. F., & Licht, C. P. B. (2008) · Kidney International · doi:10.1038/ki.2008.354 · Cited by 90
Incorporation of SP-40,40 into the solyble membrance attack complex(SMAC, SC5b-9) of complement
Choi, N.-H., Nakano, Y., Tobe, T., Mazda, T., & Tomita, M. (1990) · International Immunology · doi:10.1093/intimm/2.5.413 · Cited by 66
Cited by
Goodship, T. H. J., Cook, H. T., Fakhouri, F., Fervenza, F. C., Frémeaux-Bacchi, V., Kavanagh, D., Nester, C. M., Noris, M., Pickering, M. C., Rodríguez de Córdoba, S., et al. (2017) · Kidney International · doi:10.1016/j.kint.2016.10.005 · Cited by 701
Self-citationClinical promise of next-generation complement therapeutics
Mastellos, D. C., Ricklin, D., & Lambris, J. D. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0031-6 · Cited by 343
Sethi, S., Haas, M., Markowitz, G. S., D’Agati, V. D., Rennke, H. G., Jennette, J. C., Bajema, I. M., Alpers, C. E., Chang, A., Cornell, L. D., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015060612 · Cited by 316
Self-citationC3 Glomerulopathy: Clinicopathologic Features and Predictors of Outcome
Medjeral-Thomas, N. R., O’Shaughnessy, M. M., O’Regan, J. A., Traynor, C., Flanagan, M., Wong, L., Teoh, C. W., Awan, A., Waldron, M., Cairns, T., et al. (2014) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04700513 · Cited by 256
Diseases of complement dysregulation-an overview
Wong, E. K. S., & Kavanagh, D. (2018) · Seminars in Immunopathology · doi:10.1007/s00281-017-0663-8 · Cited by 115
Metadata
- Authors
- Sethi, S., Fervenza, F. C., Zhang, Y., Zand, L., Vrana, J. A., Nasr, S. H., Theis, J. D., Dogan, A., & Smith, R. J. H.
- Venue
- Kidney International
- Publisher
- Elsevier BV
- Published
- 2012-08
- Volume
- 82
- Issue
- 4
- Pages
- 465-473
- ISSN
- 0085-2538 (ISSN-L)
- OpenAlex
- W1977818941
- Cited by
- 299
- References
- 21
- FWCI
- 11.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.